general talk, page-150

• Emyria has a green light to commence a ground-breaking trial on MDMA-assisted therapy for Post-Traumatic Stress Disorder (PTSD)!

• Emyria is leveraging its unique partnership with the PAX Centre, Australia's leading trauma-focused psychiatric service

• Emyria's collaborative relationship with PAX distinguishes Emyria as the sole group in Australia partnered with a comprehensive, trauma-focused multidisciplinary psychiatric service

• Emyria advocates that psychedelic-assisted therapies should be provided within comprehensive mental health services - like PAX - to ensure maximum patient safety

• Emyria & PAX now is uniquely positioned in Australia with its combination of trained therapists, reliable drug supply, an active community-based psychiatrist service, Real-World Data capture expertise and now, an ethics-approved protocol

• Emyria is greatly expanding treatment options for patients with PTSD advancing Emyria's aims to become the leading provider, and developer, of innovative therapies for challenging mental health conditions